What topic would you like discussed? Text us!

In this new episode of “Food Allergy and Your Kiddo,” Dr. Hoyt discusses the recent news regarding Palforzia, the first FDA-approved treatment for peanut allergies, which is set to be discontinued. She explains how Palforzia works, its significance in oral immunotherapy (OIT), and the implications of its discontinuation for patients. Dr. Hoyt also addresses the challenges and limitations of Palforzia, including insurance coverage and the preferences of parents for more accessible alternatives like peanut butter. The conversation emphasizes the importance of discussing transitioning options with allergists and the ongoing viability of OIT without Palforzia.

Resources

📖 Navigating Food Allergies: A Parent’s Guide to Care, Coverage, and Confidence by Dr. Alice Hoyt - preorder from Amazon and more

For Parents ➡️ Office Hours for Parents

For Providers ➡️ Food Allergy Pediatric Hub

For Schools ➡️ Code Ana

For Potential Patients ➡️ Hoyt Institute of Food Allergy

🔎 Find an Allergist
AAAAI Allergist Finder
ACAAI Allergist Finder
OIT Allergist Finder

This podcast is the official podcast of the Hoyt Institute of Food Allergy. Information on, within, and associated with this site and Food Allergy and Your Kiddo is for educational purposes only and is not medical advice.